Pediatrix Medical (MD) Accounts Payables (2009 - 2026)

Pediatrix Medical has disclosed Accounts Payables across 12 years of filings, most recently posting $236.9 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 437.01% year-over-year to $236.9 million; the TTM figure through Mar 2026 stood at $236.9 million (up 437.01% YoY), while the FY2025 annual figure was $419.5 million, up 5.23% from the prior year.
• Accounts Payables fell to $236.9 million in Q1 2026, from $419.5 million in the prior quarter.
• Over the last five years, Accounts Payables for MD reached as high as $419.5 million in Q4 2025 and fell as low as $31.0 million in Q2 2023.
• The 5-year median for Accounts Payables is $269.8 million (2023), against an average of $223.6 million.
• Annual changes were most pronounced in 2023 — Accounts Payables slumped 90.76% — and 2024, when it surged 1052.68%.
• A 5-year view of Accounts Payables shows it stood at $374.2 million in 2022, then tumbled by 90.76% to $34.6 million in 2023, then surged by 1052.68% to $398.7 million in 2024, then climbed by 5.23% to $419.5 million in 2025, then sank by 43.52% to $236.9 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $236.9 million, $419.5 million, and $352.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.